These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25944815)

  • 1. Telcagepant--almost gone, but not to be forgotten (invited editorial related to Ho et al., 2015).
    Gottschalk PC
    Cephalalgia; 2016 Feb; 36(2):103-5. PubMed ID: 25944815
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
    Ho TW; Ferrari MD; Dodick DW; Galet V; Kost J; Fan X; Leibensperger H; Froman S; Assaid C; Lines C; Koppen H; Winner PK
    Lancet; 2008 Dec; 372(9656):2115-23. PubMed ID: 19036425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study.
    Behm MO; Blanchard RL; Murphy MG; Palcza JS; Harris DE; Butterfield KL; Smith WB; Preston RA; Chodakewitz JA; Krucoff MW
    Headache; 2011 Jun; 51(6):954-60. PubMed ID: 21631478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
    Ho TW; Ho AP; Chaitman BR; Johnson C; Mathew NT; Kost J; Fan X; Aurora SK; Brandes JL; Fei K; Beebe L; Lines C; Krucoff MW
    Headache; 2012 Feb; 52(2):224-35. PubMed ID: 22221076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
    Ho TW; Connor KM; Zhang Y; Pearlman E; Koppenhaver J; Fan X; Lines C; Edvinsson L; Goadsby PJ; Michelson D
    Neurology; 2014 Sep; 83(11):958-66. PubMed ID: 25107879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled study of telcagepant plus ibuprofen or acetaminophen in migraine.
    Hewitt DJ; Martin V; Lipton RB; Brandes J; Ceesay P; Gottwald R; Schaefer E; Lines C; Ho TW
    Headache; 2011 Apr; 51(4):533-43. PubMed ID: 21457238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: results from a randomized study in patients with migraine.
    Depré M; Macleod C; Palcza J; Behm M; de Lepeleire I; Han T; Panebianco D; Smith W; Blanchard R; Chodakewitz J; Murphy M; de Hoon J
    Cephalalgia; 2013 Dec; 33(16):1292-301. PubMed ID: 23798725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries.
    Chan KY; Edvinsson L; Eftekhari S; Kimblad PO; Kane SA; Lynch J; Hargreaves RJ; de Vries R; Garrelds IM; van den Bogaerdt AJ; Danser AH; Maassenvandenbrink A
    J Pharmacol Exp Ther; 2010 Sep; 334(3):746-52. PubMed ID: 20573757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine.
    Tepper SJ; Cleves C
    Curr Opin Investig Drugs; 2009 Jul; 10(7):711-20. PubMed ID: 19579177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine.
    Tfelt-Hansen P
    Headache; 2011 Jan; 51(1):118-23. PubMed ID: 21070229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina.
    Chaitman BR; Ho AP; Behm MO; Rowe JF; Palcza JS; Laethem T; Heirman I; Panebianco DL; Kobalava Z; Martsevich SY; Free AL; Bittar N; Chrysant SG; Ho TW; Chodakewitz JA; Murphy MG; Blanchard RL
    Clin Pharmacol Ther; 2012 Mar; 91(3):459-66. PubMed ID: 22278333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A flexible and high throughput liquid chromatography-tandem mass spectrometric assay for the quantitation of telcagepant in human plasma.
    Du L; Miller-Stein CM; Valesky RJ; Martucci AN; Woolf EJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1465-71. PubMed ID: 19346171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, controlled trial of telcagepant over four migraine attacks.
    Ho AP; Dahlöf CG; Silberstein SD; Saper JR; Ashina M; Kost JT; Froman S; Leibensperger H; Lines CR; Ho TW
    Cephalalgia; 2010 Dec; 30(12):1443-57. PubMed ID: 20974601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor antagonist, in adults.
    Han TH; Blanchard RL; Palcza J; McCrea JB; Laethem T; Willson K; Xu Y; Ermlich S; Boyle J; Lines C; Gutierrez M; Van Bortel L; Xiao AJ; Sinclair S; Hickey L; Panebianco D; Murphy MG
    J Clin Pharmacol; 2010 Dec; 50(12):1367-76. PubMed ID: 20173082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration.
    Wrona MZ; Yang Z; Zhang F; Dryhurst G
    NIDA Res Monogr; 1997; 173():146-74. PubMed ID: 9260188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drugs in migraine treatment and prophylaxis: telcagepant and topiramate.
    Edvinsson L; Linde M
    Lancet; 2010 Aug; 376(9741):645-55. PubMed ID: 20416945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gone but not completely forgotten: pictorial review of "antiquated" radiologic procedures--erratum.
    Flug JA; Lee RS; Giordano M; Cohen SL; Scalcione LR; Irwin GA; Katz DS; Rackson M; Mindelzun RE
    Radiographics; 2015; 35(2):651. PubMed ID: 25763748
    [No Abstract]   [Full Text] [Related]  

  • 18. Forgotten but not gone.
    Northup GW
    J Am Osteopath Assoc; 1980 Jan; 79(5):296. PubMed ID: 7351369
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurosyphilis--forgotten but not gone.
    Bierman D; Mathew RJ; Rozear M; Flyer J
    N C Med J; 1989 Mar; 50(3):157-8. PubMed ID: 2710225
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries.
    Lynch JJ; Regan CP; Edvinsson L; Hargreaves RJ; Kane SA
    J Cardiovasc Pharmacol; 2010 May; 55(5):518-21. PubMed ID: 20164785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.